Items where authors include "Ruiz Borrego, M"

Article

Martin, M, Holmes, FA, Ejlertsen, B et al. (32 more authors) (2017) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology, 18 (12). pp. 1688-1700. ISSN 1470-2045